Matthias Lucke

Coriolis Pharma

Coriolis is a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs and vaccines. As a privately held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients. We offer a large selection of services for all types of biopharmaceuticals, including proteins, peptides, peptides, nucleic acids, gene- and cell therapy products, vaccines and virus(-like) particles up to biosafety level S2. Formulation research and development (from pre-formulation to market formulations) Analytical method development (aggregate and particle characterization, protein analytics, GMP analytics) Forced degradation and stability testing (stress conditions tailored for the product, stability testing according ICH) Lyophilization (cycle development, scale up, modern PAT-tools) Supply of pre-clinical material (GMP-like conditions in clean room)